Cell transplantation therapies have become a major focus in pre-clinical research as a
promising strategy for the treatment of spinal cord injury (SCI). In this article, we …

Acute spinal cord injury (SCI) is a devastating neurological disorder that can affect any
individual at a given instance. Current treatment options for SCI include the use of high dose …

Several experimental studies have introduced Schwann cell transplantation as a means of
recovery in animal models of spinal cord injury (SCI). The reported promising results …

Object Many experimental studies on spinal cord injuries (SCIs) support behavioral
improvement after Schwann cell treatment. This study was conducted to evaluate safety …

More than 1 million people in the United States live with a spinal cord injury (SCI). Despite
medical advances, many patients with SCIs still experience substantial neurological …

Peripheral nerve injuries can lead to lifetime loss of function and permanent disfigurement.
Different methods, such as conventional allograft procedures and use of biologic tubes …

Spinal cord injury (SCI) leads to social and psychological problems in patients and requires
costly treatment and care. In recent years, various pharmacological agents have been tested …

Cellular therapy for spinal cord injury (SCI) is overviewed focusing on bone marrow
mononuclear cells, olfactory ensheathing cells, and mesenchymal stem cells. A case is …

The aim of this study was to produce a chitosan–cross-linked nanofibrous biodegradable
poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nerve conduit. The artificial nerve scaffold …

Trauma to the spinal cord produces endogenously irreversible tissue and functional loss,
requiring the application of therapeutic approaches to achieve meaningful restoration …